I would certainly like those royalties! But I think from memory Tamiflu cost substantially more per dose and the % royalty is a lot higher. So even selling equal numbers the royalty to BTA would be 2-5 * less?
The latest Taylor Collision broker forecast is certainly a lot less than this although they were not anticipating sales orders for the rotahaler.
I would argue differently on these issues though, as stated in my previous post:
http://www.hotcopper.com.au/post_single.asp?fid=1&tid=1150399&msgid=6454140
Add to My Watchlist
What is My Watchlist?